A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...

By Sukriti Gupta and Medha Singh (Reuters) -European shares slumped on Friday as China hit back with steep tariffs days after ...

Broad-based skin cancer screening may strain healthcare resources and lead to overdiagnosis, but it may also help catch more ...

Destampasidis requested media coverage of the trial - Maria Marangelis, the former protected witness "Ekaterini Kelesi", is ...

Approval was based on results from the Phase III ALIGN study, which demonstrated a significant reduction in proteinuria at 36 ...

Novartis’ Vanrafia (atrasentan) has been granted accelerated approval by the US Food and Drug Administration (FDA) to treat ...

Of all the countries that expected to be immune to President Trump’s tariffs, Switzerland was at the top of the list. The ...

Treatment with tolebrutinib led to greater confirmed disability improvement at 6 months compared with placebo in patients ...

Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...

The US FDA has granted accelerated approval to atrasentan (Vanrafia) for reducing proteinuria in adults with primary ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Gene therapy companies have faced numerous setbacks over the last few years. What will it take for gene therapies to fulfill ...